MarketLens MarketLens
US: 2026-06-12 NSE: 2026-06-12 2026-06-14
Negative
Menu

Stock Lookup

Search by symbol or company name, then inspect the chart and stock properties.

US

RLMD Relmada Therapeutics, Inc.

TradingView As Of 6/12/26
Analyst Data
Refresh analyst earnings estimates and rating summary for this symbol only.
Close
6.7700
Day %
3.91%
RS
95
RS 1D
95
RS 1W
96
RS 1M
98
RS 3M
99
RS 6M
N/A
Consensus Rating
Buy
Current Quarter EPS
-0.18
Next Quarter EPS
-0.19
Current Year EPS
-0.72
Next Year EPS
-1.18
ExchangeUS
Market Cap0 B
52W High8.0000
From 52W High-15.38%
Open6.5500
High6.9500
Low6.5100
OptionsNo
ActiveYes
RS TypeFull
RS Date2026-06-12
Bars Available309
Scanner Hits4
Last Scanner Hit2026-05-29

Recent Scanner History

4 matching / 4 total
Reset
Date Scanner RS
2026-05-29 Contraction
US_CONTRACTION
97
2026-05-28 Contraction
US_CONTRACTION
97
2026-05-19 Setup Scan
US_PPC
98
2026-05-14 Contraction
US_CONTRACTION
98

Analyst Snapshot

As Of 3/29/26
Consensus Current Quarter EPS Next Quarter EPS Current Year EPS Next Year EPS
Buy -0.18 -0.19 -0.72 -1.18
Based on 4 analysts offering recommendations for 'RLMD'.

Quarterly EPS Forecasts

5 rows
Period Consensus EPS High Low Estimates Revisions
Mar 2026 -0.18 -0.17 -0.19 2
0 1
Jun 2026 -0.19 -0.18 -0.19 2
0 0
Sep 2026 -0.20 -0.20 -0.20 2
1 0
Dec 2026 -0.22 -0.21 -0.23 2
1 0
Mar 2027 -0.27 -0.27 -0.27 1
0 0

Yearly EPS Forecasts

2 rows
Period Consensus EPS High Low Estimates Revisions
Dec 2026 -0.72 -0.60 -0.79 3
1 0
Dec 2027 -1.18 -1.11 -1.24 2
1 0